• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溴隐亭治疗后人类垂体肿瘤的结构变化。

Structural changes in human pituitary tumor after bromocriptine therapy.

作者信息

Rengachary S S, Tomita T, Jefferies B F, Watanabe I

出版信息

Neurosurgery. 1982 Feb;10(2):242-51.

PMID:7070622
Abstract

The histological appearance of a prolactin-producing tumor and of a growth hormone-producing tumor after short term bromocriptine therapy was studied in detail using light microscopy with conventional and immunocytochemical methods and using transmission electron microscopy. The findings were correlated with clinical, radiological, and biochemical data. Histological changes consisting of clumping of nuclear chromatin and a marked reduction in cytoplasmic volume due to loss of ribosomes, rough endoplasmic reticulum, and Golgi complexes were observed only in the prolactin-producing tumor. Normalization of elevated serum prolactin levels and reduction in size of the tumor observed in serial computed tomograms correlated with striking histological changes found in the tumor. These changes were interpreted to represent a reversible inhibition of the protein-synthetic machinery of the neoplastic cell. Comparable clinical, biochemical, radiological, or structural changes were not observed in the growth hormone-secreting tumor.

摘要

采用常规和免疫细胞化学方法的光学显微镜以及透射电子显微镜,对短期使用溴隐亭治疗后的催乳素分泌瘤和生长激素分泌瘤的组织学表现进行了详细研究。研究结果与临床、放射学和生化数据相关联。仅在催乳素分泌瘤中观察到由核染色质聚集以及由于核糖体、粗面内质网和高尔基体复合物丢失导致的细胞质体积显著减少所组成的组织学变化。在连续计算机断层扫描中观察到血清催乳素水平升高的正常化以及肿瘤大小的减小,这与肿瘤中发现的显著组织学变化相关。这些变化被解释为代表肿瘤细胞蛋白质合成机制的可逆性抑制。在生长激素分泌瘤中未观察到类似的临床、生化、放射学或结构变化。

相似文献

1
Structural changes in human pituitary tumor after bromocriptine therapy.溴隐亭治疗后人类垂体肿瘤的结构变化。
Neurosurgery. 1982 Feb;10(2):242-51.
2
Tissue kallikrein and the effect of bromocriptine in human prolactin and growth hormone-secreting pituitary adenomas.组织激肽释放酶及溴隐亭对人泌乳素及生长激素分泌型垂体腺瘤的作用。
Agents Actions Suppl. 1992;38 ( Pt 2):175-82.
3
[Size reduction of a nonfunctioning pituitary adenoma after bromocriptine therapy: case report].
No Shinkei Geka. 1984 Jan;12(1):71-80.
4
Clinical and pathological effects of bromocriptine on prolactin-secreting and other pituitary tumors.溴隐亭对催乳素分泌性垂体瘤及其他垂体瘤的临床和病理影响。
J Neurosurg. 1984 Jan;60(1):1-7. doi: 10.3171/jns.1984.60.1.0001.
5
Reduction in size of a pituitary tumor by bromocriptine therapy.
N Engl J Med. 1979 Feb 8;300(6):291-3. doi: 10.1056/NEJM197902083000606.
6
Human prolactin-producing adenomas and bromocriptine: a histological, immunocytochemical, ultrastructural, and morphometric study.人催乳素分泌性腺瘤与溴隐亭:一项组织学、免疫细胞化学、超微结构及形态计量学研究。
J Clin Endocrinol Metab. 1982 Dec;55(6):1178-83. doi: 10.1210/jcem-55-6-1178.
7
Computed tomographic demonstration of the effects of bromocriptine on pituitary microadenoma size.溴隐亭对垂体微腺瘤大小影响的计算机断层扫描显示
Radiology. 1982 May;143(2):451-5. doi: 10.1148/radiology.143.2.7071347.
8
Necrotic changes in prolactinomas after long term administration of bromocriptine.
J Clin Endocrinol Metab. 1984 Sep;59(3):463-70. doi: 10.1210/jcem-59-3-463.
9
[Complete regression of prolactin-secreting pituitary tumors by bromocriptine therapy (author's transl)].溴隐亭治疗使催乳素分泌型垂体瘤完全消退(作者译)
No Shinkei Geka. 1980 Oct;8(10):981-6.
10
Reduction of pituitary-tumour size in patients with prolactinomas and acromegaly treated with bromocriptine with or without radiotherapy.接受溴隐亭治疗(无论是否联合放疗)的催乳素瘤和肢端肥大症患者垂体肿瘤大小的缩小情况。
Lancet. 1979 Jul 14;2(8133):66-9. doi: 10.1016/s0140-6736(79)90120-x.

引用本文的文献

1
Long-Term Follow-Up Over 16 Years for Pituitary Hyperplasia Due to Primary Hypothyroidism With Positive Thyroid Stimulation Blocking Antibody: A Case Report.原发性甲状腺功能减退伴甲状腺刺激阻断抗体阳性所致垂体增生的16年长期随访:一例报告
Cureus. 2023 Aug 20;15(8):e43823. doi: 10.7759/cureus.43823. eCollection 2023 Aug.
2
Decrease of Proliferative Potential and Vascular Density of Giant Prolactinoma in Patients Treated with Cabergoline.卡麦角林治疗的巨大泌乳素瘤患者增殖潜能和血管密度的降低
Asian J Neurosurg. 2020 May 29;15(2):385-390. doi: 10.4103/ajns.AJNS_16_20. eCollection 2020 Apr-Jun.
3
Short-term morphologic and functional effects of bromocriptine on pituitary prolactin cell adenomas in vitro.
溴隐亭对垂体催乳素细胞腺瘤的短期形态学和功能影响(体外实验)
Endocr Pathol. 1993 Jun;4(2):79-85. doi: 10.1007/BF02914456.
4
Pituitary apoplexy during treatment of cystic macroprolactinomas with cabergoline.使用卡麦角林治疗囊性大泌乳素瘤期间发生垂体卒中。
Pituitary. 2008;11(3):287-92. doi: 10.1007/s11102-007-0046-6.
5
Effect of dopamine agonists on prolactinomas and normal pituitary assessed by dynamic contrast enhanced magnetic resonance imaging (DCE-MRI).通过动态对比增强磁共振成像(DCE-MRI)评估多巴胺激动剂对催乳素瘤和正常垂体的影响。
Pituitary. 2007;10(3):261-6. doi: 10.1007/s11102-007-0048-4.
6
Effect of Dopamine Agonists on Lactotroph Adenomas of the Human Pituitary.多巴胺激动剂对人垂体催乳素瘤的作用。
Endocr Pathol. 2000 Winter;11(4):341-352. doi: 10.1385/ep:11:4:341.
7
Topical effect of bromocriptine on rat-transplanted human prolactinomas.
Acta Neurochir (Wien). 1993;120(3-4):175-9. doi: 10.1007/BF02112038.
8
Bromocriptine treatment of macroprolactinomas: studies on the time course of tumor shrinkage and morphology.溴隐亭治疗大泌乳素瘤:肿瘤缩小时间进程及形态学研究
J Endocrinol Invest. 1982 Nov-Dec;5(6):409-15. doi: 10.1007/BF03350542.
9
Bromocriptine reduces the size of cells in prolactin-secreting pituitary adenomas.溴隐亭可减小分泌催乳素的垂体腺瘤中的细胞大小。
Experientia. 1983 Jun 15;39(6):625-6. doi: 10.1007/BF01971131.
10
Effect of acrylonitrile on the rat pituitary: enlargement of Golgi region in prolactin cells, crinophagy in prolactin cells and growth hormone cells.丙烯腈对大鼠垂体的影响:催乳素细胞中高尔基体区域增大、催乳素细胞和生长激素细胞中出现自噬溶酶体现象。
Br J Exp Pathol. 1986 Jun;67(3):439-51.